Patent assignee · US · COMPANY

Jenrin Discovery, LLC

27Patents
27Active
27Granted
51Portfolio score

Filing activity: Jun 1, 2006 → Mar 4, 2020 · 17 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7655685B2 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Chemistry; Metallurgy 50 Active
US8133904B2 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity Chemistry; Metallurgy 26 Active
US7482470B2 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Chemistry; Metallurgy 18 Active
US7666889B2 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Chemistry; Metallurgy 14 Active
US8088809B2 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Chemistry; Metallurgy 12 Active
US7687481B2 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity Chemistry; Metallurgy 9 Active
US8334282B2 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Human Necessities 7 Active
US9987253B2 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Chemistry; Metallurgy 7 Active
US9517228B2 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Chemistry; Metallurgy 7 Active
US8138216B2 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Chemistry; Metallurgy 6 Active
US8580768B2 Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes Chemistry; Metallurgy 5 Active
US8138209B2 Substituted picolinamides as MAO-B inhibitors useful for treating obesity Chemistry; Metallurgy 4 Active
US8680131B2 Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers Chemistry; Metallurgy 2 Active
US8236821B2 Substituted N-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity Chemistry; Metallurgy 1 Active
US8217038B2 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Chemistry; Metallurgy 1 Active
US8252791B2 Purine compounds as cannabinoid receptor blockers Chemistry; Metallurgy 1 Active
US11179370B2 Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers Chemistry; Metallurgy 0 Active
US8541475B2 MAO-B inhibitors useful for treating obesity Chemistry; Metallurgy 0 Active
US7956220B2 MAO-B inhibitors useful for treating obesity Chemistry; Metallurgy 0 Active
US10617673B2 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Chemistry; Metallurgy 0 Active
US8088926B2 Substituted 2-methyl-2-phenoxy-N-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity Chemistry; Metallurgy 0 Active
US8853252B2 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Chemistry; Metallurgy 0 Active
US9133127B2 Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers Chemistry; Metallurgy 0 Active
US8716265B2 4-quinolinemethanols as anti-malarial agents Emerging Cross-Sectional Technologies 0 Active
US8648072B2 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.